Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell TransplantRuihao Huang, Xi Zhang, Xiangyu Ma et al.|JAMA Oncology|2023Cited by 53
Amplifying STING activation by bioinspired nanomedicine for targeted chemo- and immunotherapy of acute myeloid leukemiaXiaoqi Wang, Xi Zhang, Ruihao Huang et al.|Acta Biomaterialia|2022Cited by 32
Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-GenzymeLu Wang, Peiyan Kong, Cheng Zhang et al.|Annals of Hematology|2023Cited by 11
Efficacy and toxicity of <scp>CLAG</scp> combined with pegylated liposomal doxorubicin in the treatment of refractory or relapsed acute myeloid leukemiaHan Yao, Xi Zhang, Cheng Zhang et al.|Cancer Medicine|2023Cited by 10
Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemiaYimei Feng, Peiyan Kong, Ting Chen et al.|Frontiers in Immunology|2023Cited by 4